Globally, healthcare systems are navigating unprecedented challenges: escalating costs, rapidly ageing populations and a crucial shift towards more personalised patient care. Amid this complex landscape, Globant is making significant strides, contributing to solutions through its innovative applications of artificial intelligence (AI). In a world increasingly shaped by digital advancements, Globant is actively participating in the evolution of healthcare – from improving integration across diverse services and providers to facilitating the transition towards tailored treatments for individual patients.
Globant is driving this transformation by deeply embedding AI and intelligent systems into critical areas such as clinical research, hospital management and pharmaceutical operations. The tangible impact of these innovations is already clear:
• For patients, they promise faster access to essential clinical trials and the development of safer, more seamless hospital experiences.
• For clinicians, these solutions offer invaluable time-saving tools, allowing them to dedicate more of their most valuable asset – time – to direct patient care and high-value tasks.
• For health systems, they provide robust, data-driven insights that are crucial for improving operational efficiency and achieving significant cost reductions.
• For pharmaceutical companies, Globant's AI enables more targeted and effective operations across the entire drug development life cycle.
Globant's solutions are meticulously developed to address the inherent challenges and concerns associated with transforming the sector with AI tools and applications. Their platforms prioritise interoperability, ensuring seamless integration with existing electronic health records, advanced imaging systems, laboratory services, wearable devices and comprehensive pharmaceutical databases.
Crucially, Globant's systems are also designed with robust safeguards to ensure strict compliance with privacy regulations, such as GDPR. Furthermore, they actively monitor for algorithmic bias, a vital step in ensuring fair and equitable outcomes across diverse patient populations. Recognising the human element, Globant also emphasises clinician training and the establishment of clear governance structures, both of which are central to fostering widespread adoption and building trust in new AI tools within healthcare settings.
Globant’s ambitions in healthcare received a significant boost in April 2023 with the strategic acquisition of Minneapolis-based consultancy ExperienceIT. This development not only substantially expanded Globant’s footprint in North America, but also enhanced its capabilities in digital transformation, particularly in areas such as IT modernisation and optimising the healthcare-provider experience. This acquisition has provided Globant with invaluable insights into the region’s health-tech ecosystem, better equipping it to support healthcare clients through their complex digital transitions.
The acquisition of Common MS in mid-2024 by Globant represents another highly strategic move with profound implications for the hospital sector across Europe, Latin America and the Middle East. Common MS's value in the healthcare realm is significantly amplified by its specialisation in developing and implementing the ECH Easy Healthcare system. This robust system, specifically designed for comprehensive hospital information management,
has firmly established Common MS’s presence in key healthcare institutions throughout these regions.
The integration of Common MS and its proven ECH Easy Healthcare solution into Globant not only considerably expands Globant’s service offerings, but also strategically positions it as a pivotal player in the ongoing modernisation of hospital technological infrastructure. At a time when digitalisation, operational efficiency and meticulous patient data management are more critical than ever for global healthcare systems, the synergy between Globant's innovative agility and Common MS’s in-depth knowledge of hospital information systems promises to accelerate the implementation of advanced technologies. This encompasses everything from optimising intricate clinical workflows to enhancing data-driven decision-making, thereby laying the groundwork for more connected, efficient and truly personalised patient care. This operation underscores a compelling trend where technology acts as the primary catalyst for transforming and improving healthcare service delivery, offering novel tools to address both current and future challenges facing the sector.
Globant is also directly integrating its AI expertise into core hospital operations and clinical documentation processes. Solutions like Ambient Scribe, Automate Clinical Documentation and Clinical Coding are now integral parts of the Healthcare Suite, significantly boosted by Globant Enterprise AI. This company platform is specifically designed to help businesses seamlessly integrate and manage AI solutions, with a particular focus on Large Language Models (LLMs), all while ensuring robust security and essential flexibility. Essentially, it empowers organisations to harness the immense power of AI without the inherent complexity of directly managing the underlying AI models.
In a landscape demanding both agility and groundbreaking solutions, Globant's ‘AI Pods’ represent a significant leap forward, not just in AI application, but fundamentally in how organisations engage with digital transformation. This pioneering subscription-based model offers on-demand access to highly specialised teams – comprising AI-powered engineering, design and product-development services – all expertly orchestrated and supervised by Globant's seasoned professionals. It signifies a fresh, flexible approach to securing top-tier AI talent and capabilities, moving beyond the traditional constraints of fixed-term, project-based contracts.
Why are these innovative engagement models particularly compelling for healthcare providers and pharmaceutical companies in the UK? They offer unparalleled flexibility and speed. Instead of enduring lengthy recruitment processes or grappling with fixed-scope projects that struggle to adapt to evolving needs, AI Pods provide a scalable, agile and continuous influx of innovation. This empowers organisations to rapidly pilot new ideas, iterate on solutions, and scale successful initiatives without the inherent overheads and rigidities of conventional setups. The result is faster time-to-value and a heightened ability to remain competitive in a rapidly evolving technological landscape.
Consider the substantial impact these flexible AI Pods can drive across various critical areas:
• Accelerating drug discovery and clinical trials Imagine rapidly deploying an AI Pod to analyse vast genomic datasets for novel drug targets, or to optimise patient recruitment for clinical trials by accurately predicting ideal candidates, thereby significantly compressing crucial development timelines.
• Enhancing personalised patient care An AI Pod could be tasked with developing intelligent systems that seamlessly integrate diverse patient data to predict disease progression, recommend highly tailored treatment plans or even create sophisticated AI-powered virtual assistants to support remote patient monitoring and engagement.
• Optimising healthcare operations From utilising AI to precisely predict bed availability and streamline resource allocation in hospitals, to optimising complex supply chain logistics for essential medicines, AI Pods can quickly build and deploy tools that drive unprecedented operational efficiencies
By providing a flexible, expert-driven conduit for AI integration, these pods empower organisations to embrace artificial intelligence effectively, driving greater efficiency, fostering continuous innovation and, ultimately, helping to navigate the complex challenges of modern healthcare.
Looking ahead, Globant is exceptionally well-positioned not merely as a technology provider, but as a genuine long-term partner in shaping the future of healthcare. With a clear commitment to ethical innovation, unwavering interoperability and collaborative approaches, the company will continue to develop robust solutions that support better outcomes for patients, clinicians and health systems alike.
As digital transformation accelerates across the sector, Globant’s forward-thinking approach ensures it is set to play an increasingly important and influential role in making healthcare more intelligent, more accessible and truly adaptive to the diverse needs of tomorrow.
Globant creates digitally-native products that bridge the gap between businesses and consumers through technology and creativity.
For more information on Globant's innovations in the healthcare sector, visit:
www.globant.com/healthcare
